NO20010514L - Aminometylkarboksylsyre-derivater - Google Patents
Aminometylkarboksylsyre-derivaterInfo
- Publication number
- NO20010514L NO20010514L NO20010514A NO20010514A NO20010514L NO 20010514 L NO20010514 L NO 20010514L NO 20010514 A NO20010514 A NO 20010514A NO 20010514 A NO20010514 A NO 20010514A NO 20010514 L NO20010514 L NO 20010514L
- Authority
- NO
- Norway
- Prior art keywords
- aminometylkarboksylsyre
- derivatives
- aminometylkarboksylsyre derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98306149 | 1998-07-31 | ||
| PCT/EP1999/005477 WO2000007978A1 (en) | 1998-07-31 | 1999-07-26 | Aminomethylcarboxylic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20010514D0 NO20010514D0 (no) | 2001-01-30 |
| NO20010514L true NO20010514L (no) | 2001-01-30 |
| NO327756B1 NO327756B1 (no) | 2009-09-14 |
Family
ID=8234975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010514A NO327756B1 (no) | 1998-07-31 | 2001-01-30 | Aminometylkarboksylsyre-derivater, slike forbindelser for anvendelse i terapi, farmasoytiske preparater inneholdende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdommer |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6410592B1 (no) |
| EP (1) | EP1100769B1 (no) |
| JP (1) | JP4290340B2 (no) |
| KR (1) | KR100640031B1 (no) |
| CN (1) | CN1191232C (no) |
| AR (1) | AR049670A1 (no) |
| AT (1) | ATE228995T1 (no) |
| AU (1) | AU762759B2 (no) |
| BR (1) | BR9912621A (no) |
| CA (1) | CA2337041C (no) |
| CO (1) | CO5080746A1 (no) |
| CZ (1) | CZ301620B6 (no) |
| DE (1) | DE69904335T2 (no) |
| DK (1) | DK1100769T3 (no) |
| ES (1) | ES2189462T3 (no) |
| HU (1) | HUP0102766A3 (no) |
| ID (1) | ID26978A (no) |
| IL (1) | IL140358A0 (no) |
| NO (1) | NO327756B1 (no) |
| NZ (1) | NZ509568A (no) |
| PL (1) | PL198041B1 (no) |
| PT (1) | PT1100769E (no) |
| RU (1) | RU2225389C2 (no) |
| SK (1) | SK286474B6 (no) |
| TR (1) | TR200100270T2 (no) |
| TW (1) | TW555757B (no) |
| WO (1) | WO2000007978A1 (no) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243173B (en) | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| RU2390519C2 (ru) * | 2003-08-29 | 2010-05-27 | Оно Фармасьютикал Ко., Лтд. | Соединение, способное к связыванию с рецептором s1p, и его фармацевтическое применение |
| DE102004030099A1 (de) * | 2004-06-22 | 2006-01-12 | Grünenthal GmbH | Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren |
| RU2433121C2 (ru) * | 2004-12-13 | 2011-11-10 | Оно Фармасьютикал Ко., Лтд. | Производное аминокарбоновой кислоты и применение указанного вещества в медицинских целях |
| JP5123669B2 (ja) * | 2005-01-14 | 2013-01-23 | エム・エス・ディー・オス・ベー・フェー | 薬物およびアルコール依存症を治療するためのグリシン再取込みインヒビター |
| KR101381768B1 (ko) * | 2006-01-06 | 2014-04-07 | 선오비온 파마슈티컬스 인코포레이티드 | 테트랄론-기재 모노아민 재흡수 저해제 |
| WO2009059961A2 (en) * | 2007-11-06 | 2009-05-14 | N.V. Organon | A method of hormone suppression in humans |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) * | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) * | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2014521682A (ja) * | 2011-08-05 | 2014-08-28 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノクロマン、アミノチオクロマンおよびアミノ−1,2,3,4−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用 |
| WO2013064206A1 (de) | 2011-11-01 | 2013-05-10 | Merck Patent Gmbh | Organische elektrolumineszenzvorrichtung |
| WO2013083216A1 (de) | 2011-11-17 | 2013-06-13 | Merck Patent Gmbh | Spiro -dihydroacridinderivate und ihre verwendung als materialien für organische elektrolumineszenzvorrichtungen |
| EP2780328A1 (en) | 2011-11-18 | 2014-09-24 | Abbvie Deutschland GmbH & Co. KG | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9425401B2 (en) | 2012-03-23 | 2016-08-23 | Merck Patent Gmbh | 9,9′-spirobixanthene derivatives for electroluminescent devices |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| MX2016004936A (es) | 2013-10-17 | 2016-12-20 | Abbvie Deutschland | Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia. |
| WO2015055771A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CN104844471B (zh) * | 2015-04-21 | 2017-05-03 | 苏州远智医药科技有限公司 | 一种作为dor受体拮抗剂的化合物 |
| US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
| SG11202002032SA (en) | 2017-09-22 | 2020-04-29 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
| CA3076476A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
| BR112020008851A2 (pt) | 2017-11-06 | 2020-10-20 | Jubilant Prodel LLC | composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas |
| PL3704120T3 (pl) | 2017-11-24 | 2024-09-16 | Jubilant Episcribe Llc | Związki heterocykliczne jako inhibitory prmt5 |
| SG11202008950PA (en) | 2018-03-13 | 2020-10-29 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
| CN110003160B (zh) * | 2019-05-14 | 2022-10-11 | 贵州中医药大学 | 一种蛇床子素腙类/酰腙类/磺酰腙类衍生物及其制备方法以及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
| US5657157A (en) * | 1995-06-23 | 1997-08-12 | Sdl, Inc. | Semiconductor optical amplifying media with reduced self-focusing |
| ATE221520T1 (de) * | 1995-09-29 | 2002-08-15 | Glaxo Wellcome Spa | Tetrahydrochinoline als nmda antagonisten |
| CZ294348B6 (cs) * | 1996-05-31 | 2004-12-15 | Allelix Neuroscience Inc. | Substituovaný derivát glycinu a farmaceutický prostředek s jeho obsahem |
| JP4403212B2 (ja) * | 1996-05-31 | 2010-01-27 | エヌピーエス ファーマシューティカルズ インコーポレイテッド | 神経障害および神経心理学的障害の治療のための製剤学的薬剤 |
-
1999
- 1999-07-23 TW TW088112566A patent/TW555757B/zh not_active IP Right Cessation
- 1999-07-26 WO PCT/EP1999/005477 patent/WO2000007978A1/en not_active Ceased
- 1999-07-26 KR KR1020017001327A patent/KR100640031B1/ko not_active Expired - Fee Related
- 1999-07-26 PL PL345794A patent/PL198041B1/pl not_active IP Right Cessation
- 1999-07-26 DK DK99939419T patent/DK1100769T3/da active
- 1999-07-26 EP EP99939419A patent/EP1100769B1/en not_active Expired - Lifetime
- 1999-07-26 CZ CZ20010398A patent/CZ301620B6/cs not_active IP Right Cessation
- 1999-07-26 CA CA002337041A patent/CA2337041C/en not_active Expired - Lifetime
- 1999-07-26 DE DE69904335T patent/DE69904335T2/de not_active Expired - Lifetime
- 1999-07-26 RU RU2001105536/04A patent/RU2225389C2/ru not_active IP Right Cessation
- 1999-07-26 PT PT99939419T patent/PT1100769E/pt unknown
- 1999-07-26 ID IDW20010234A patent/ID26978A/id unknown
- 1999-07-26 AU AU53724/99A patent/AU762759B2/en not_active Expired
- 1999-07-26 ES ES99939419T patent/ES2189462T3/es not_active Expired - Lifetime
- 1999-07-26 HU HU0102766A patent/HUP0102766A3/hu unknown
- 1999-07-26 SK SK149-2001A patent/SK286474B6/sk not_active IP Right Cessation
- 1999-07-26 JP JP2000563613A patent/JP4290340B2/ja not_active Expired - Lifetime
- 1999-07-26 NZ NZ509568A patent/NZ509568A/en not_active IP Right Cessation
- 1999-07-26 TR TR2001/00270T patent/TR200100270T2/xx unknown
- 1999-07-26 IL IL14035899A patent/IL140358A0/xx not_active IP Right Cessation
- 1999-07-26 AT AT99939419T patent/ATE228995T1/de active
- 1999-07-26 CN CNB998086649A patent/CN1191232C/zh not_active Expired - Lifetime
- 1999-07-26 US US09/744,520 patent/US6410592B1/en not_active Expired - Lifetime
- 1999-07-26 BR BR9912621-4A patent/BR9912621A/pt not_active Application Discontinuation
- 1999-07-29 AR ARP990103756A patent/AR049670A1/es active IP Right Grant
- 1999-07-30 CO CO99048379A patent/CO5080746A1/es unknown
-
2001
- 2001-01-30 NO NO20010514A patent/NO327756B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20010193D0 (no) | Tiobenzimidazol-derivater | |
| DK0930302T3 (da) | Benzosulfonderivater | |
| NO20010514D0 (no) | Aminometylkarboksylsyre-derivater | |
| ATE259810T1 (de) | Phenyl-xanthinderivate | |
| DE69934788D1 (de) | Biozide benzylbiphenylderivative | |
| DK1005446T3 (da) | N-aroylphenylalaninderivater | |
| ATE235220T1 (de) | Resorcinderivate | |
| ID22781A (id) | Turunan-turunan nikotinamida | |
| DE69808145D1 (de) | Tintenbehälternachfüllsystem | |
| DE59902874D1 (de) | Buchsenkontakt | |
| DE69817186D1 (de) | Diaminorhodamin-derivate | |
| DE69812868D1 (de) | Flanschreformierungsanlage | |
| PT928790E (pt) | Derivados de tiazolo | |
| DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
| ATE262513T1 (de) | Benzoylpyridazine | |
| DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
| PT1056716E (pt) | Derivados de ciclo-hexanodiolo | |
| DE59908769D1 (de) | N-arylsulfonyl-aminosäure-omega-amide | |
| ATE233253T1 (de) | Chromanderivate | |
| DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
| DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
| DE59903106D1 (de) | Tripode-gleichlaufdrehgelenk | |
| ATE292632T1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate | |
| DE69809804D1 (de) | Notlaufgeländereifen | |
| DK1060183T3 (da) | 5-deoxycytidinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |